Literature DB >> 16502425

Familial idiopathic hyper-CK-emia: an underrecognized condition.

Margherita Capasso1, Maria Vittoria De Angelis, Antonio Di Muzio, Oronzo Scarciolla, Marta Pace, Liborio Stuppia, Giacomo Pietro Comi, Antonino Uncini.   

Abstract

Persistent elevation of serum creatine kinase (CK) in individuals with normal neurological and laboratory examinations has been called idiopathic hyperCKemia (IH). IH has been reported in rare families and was recently ascribed to caveolin-3 gene mutations. We retrospectively found that IH was familial in 13 of 28 subjects in whom serum CK was measured in relatives. These 13 families had a total of 41 subjects with IH, including six over 60 years of age. In eight families there was male-to-male transmission and a higher prevalence of males with hyperCKemia. Muscle biopsy in one member of all families was normal or showed minimal, nonspecific changes. Morphometric examination disclosed different patterns of changes in fiber size and distribution. Caveolin-3 expression was normal and in five families molecular genetics excluded caveolin-3 gene mutations. Our findings suggest that IH is familial in 46% of cases. Familial IH is a benign genetically heterogeneous condition that is autosomal-dominant in at least 60% of cases, with a higher penetrance in men.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16502425     DOI: 10.1002/mus.20525

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  7 in total

1.  Asymptomatic hyperCKemia during a two-year monitoring period: A case report and literature overview.

Authors:  Spyridon Klinis; Athanasios Symeonidis; Dimitrios Karanasios; Emmanouil K Symvoulakis
Journal:  Biomed Rep       Date:  2016-11-30

2.  Persistent HyperCKemia in Athletes.

Authors:  Paola Brancaccio; Nicola Maffulli; Luisa Politano; Giuseppe Lippi; Francesco Mario Limongelli
Journal:  Muscles Ligaments Tendons J       Date:  2011-10-30

Review 3.  Approach to asymptomatic creatine kinase elevation.

Authors:  Siamak Moghadam-Kia; Chester V Oddis; Rohit Aggarwal
Journal:  Cleve Clin J Med       Date:  2016-01       Impact factor: 2.321

4.  Malignant Hyperthermia and Idiopathic HyperCKemia.

Authors:  Pashtoon Murtaza Kasi
Journal:  Case Rep Med       Date:  2011-11-23

5.  A novel 1-bp deletion variant in DAG1 in Japanese familial asymptomatic hyper-CK-emia.

Authors:  Luoming Fan; Shiroh Miura; Tomofumi Shimojo; Hirotoshi Sugino; Ryuta Fujioka; Hiroki Shibata
Journal:  Hum Genome Var       Date:  2022-01-27

6.  Idiopathic Benign Hyper-CK-Emia.

Authors:  Prashant Kaushik; Anuradha Gonuguntla
Journal:  Int J Biomed Sci       Date:  2009-03

7.  Malignant hyperthermia.

Authors:  Dong-Chan Kim
Journal:  Korean J Anesthesiol       Date:  2012-11-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.